The document discusses the growing trend of outsourcing in drug development, particularly within the contract research organization (CRO) market, where pharmaceutical companies are increasingly relying on external partners to reduce costs and accelerate drug development timelines. The report outlines the challenges and drivers behind this shift, including rising development costs and the high failure rates during clinical trials. It provides comprehensive market analysis, including statistics, forecasts, and profiles of key industry players.

1. Outsourcing in Drug Development : The Contract Research (Clinical Trial) Market

2. About Us MarketResearch.com is the world's largest and continuously updated collection of market research. As your single source for market intelligence, we offer more than 300,000 market research reports from over 700 leading global publishers. Our Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries. They give you unbiased and qualitative insights on which reports will best meet your needs. Whether you’re looking for new product trends or competitive analysis of a new or existing market, MarketResearch.com has the best research offerings and the expertise to make sure you get the right report every time. Don’t limit your choices. See why leading companies trust MarketResearch.com again and again to gain and maintain a competitive edge in new and existing markets.

3. Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if not longer. Because of this, major pharmaceutical marketers continue to outsource stages of development, and over the years Kalorama Information has observed this process. In past editions of our outsourcing market studies, we found that outsourcing moved from "should" to "must." for manufacturers. This trend has only continued in the past two years. Contract Research Organizations (CROs) and other entities can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to market is ever-increasing and intensifying. A key cost driver is the large number of failures during the expensive clinical trial phases. Driven by pressures to reduce costs, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. Kalorama Information's Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues.

4. As part of its comprehensive coverage of this market, this report contains: A Detailed Introduction to the Clinical Trial Process Statistics of Drugs in Development by Phase Market Size and Forecasts for Outsourcing In Drug Development by Academic Medical Center (AMC), Contract Research Organizations and Others. Main Drivers for Outsourcing in Drug Development How CROs are Meeting the Challenge of Patient Recruitment Discussion of Industry and Regulatory Trends Protocols Funded in FY2009 by Percent and Gender Global R&D Expenditures Outsourced by Percent 2003-2010 Selected Pharmaceutical Company Acquisitions, 2009-2011 Top Ten Therapeutic Categories in R&D Selected Acquisitions of Leading CROs Increasing role of EDCs Globalization Trends in Drug Development and Breakout of Clinical Trials by Region Directory of Companies Market Share of Major CROs 2011 Profiles of CROs, Contract Laboratories, Clinical Trial Labs and EDC Solution Companies

5. Contract Research Organizations As part of Kalorama Information's research process, information for this report is gathered from sources including trade press, company reports and government databases. Kalorama Information's analyst also interviewed dozens of experts in the industry to discover new trends and confirm assumptions. As part of the report's coverage , the following CROs, clinical trial laboratories, EDC companies and site management networks are profiled: Charles River Laboratories International, Inc. Covance, Inc. Encorium, Inc. Icon, PLC Parexel International Corporation Medical Marketing Services Pharmaceutical Product Development, Inc INC Research InVentiv Health Pra International Quintiles Transnational Corporation Radiant Development Theorem Clinical Research Bioanalytical Research Corporation Calvert Laboratories, Inc Crl Medinet Kronos Sicence Laboratories LabCorp MedTox Scientific Inc. Pacific Biomarkers, Inc. eResearch Technology, Inc. PRL Central Laboratory Services SMO-USA, Inc. Pharsight Corporation Phase Forward, Inc. Medidata Solutions Worldwide Perceptive Informatics, Inc. EDC Solutions

6. For More this Report and Additional Research Visit MarketResearch .com Or call 1-800-298-5699